Wise John Drayton's Form 4 filing
INSMED Inc (INSM) · filed Jan 5, 2024
- Accession no.
- 0001628280-24-000698
- Filed
- Jan 5, 2024
- Trade date
- Jan 3-5, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $620.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Wise John DraytonCIK 0001930805 | Officer (Chief Commercial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 3, 2024 | Stock Option (right to buy) | MOption exerciseAcquired | +20,071 | $19.11 | +$383,556.81 | 124,055 | Direct | |
| Jan 3, 2024 | Stock Option (right to buy) | SSaleDisposed | −20,071 | $29.19F3 | −$585,872.49 | 103,984 | Direct | |
| Jan 4, 2024 | Common Stock | AGrant or awardAcquired | +12,873 | –F5 | – | 116,857 | Direct | |
| Jan 5, 2024 | Common Stock | SSaleDisposed | −1,167 | $29.32 | −$34,216.44 | 115,690 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 3, 2024 | Common Stock | MOption exerciseDisposed | −20,071 | $0.00 | $0 | 0 | Direct | |
| Jan 4, 2024 | Common Stock | AGrant or awardAcquired | +63,560 | $0.00 | $0 | 63,560 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F3
This is the weighted average sales price representing 20,071 shares sold at prices ranging from $28.915 to $29.39 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
Referenced by the price of 1 transaction in Table I.
- F5
Each Restricted Stock Unit was received as a grant on January 4, 2024, for no consideration.
Referenced by the price of 1 transaction in Table I.